Access Dermatology

Latest Clinical Trials

• Omalizumab in eczema

  Summary

  Anti-IgE in severe atopic eczema with high serum IgE levels

• Ingenol mebutate in actinic keratosis: The PEP005-014 study

  Summary

  Peplin to start phase III under SPA agreement with FDA

• KC-706 in pemphigus: The NCT00606749 study

  Summary

  Use of KC706 for the treatment of Pemphigus vulgaris (NCT00606749)

• Fibrin sealant in burning: The NCT00157131 study

  Summary

  Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: Results of a phase 3 clinical study

• Etanercept in rheumatoid arthritis

  Summary

  Clinical trial safety data of events of interest in patients receiving etanercept across approved indications

• PV-10 in atopic dermatitis

  Summary

  Provectus Pharmaceuticals, Inc. begins phase 2 clinical trial for atopic dermatitis

• Pyratine 6 in acne rosacea

  Summary

  Effects of PRK 124 (0.125%) lotion in acne rosacea

• HO/03/03 in diabetic foot ulcers

  Summary

  Novel drug treatment for diabetic foot ulcers-results of a phase I clinical study

• Epiceram vs. pimecrolimus in atopic dermatitis

  Summary

  Ceragenix announces results of a comparison study of the safety and efficacy of EpiCeram cream for the treatment of mild to moderate pediatric atopic dermatitis

• Sevoflurane in burning

  Summary

  Use of sevoflurane sedation by the AnaConDa device as an adjunct to extubation in a pediatric burn patient